Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

4SCAR19 Chimeric Antigen Receptor-Modified T Cells As a Breakthrough Therapy for Highly Chemotherapy-Resistant Late-Stage B Cell Lymphoma Patients with Bulky Tumor Mass

Lung-Ji Chang, PhD, Lujia Dong, MD, Jun Zhu, MD, Zhitao Ying, MD, Hao-Hsian Kuo, MSc, Yuchen Liu, MSc, Yu-Qin Song, MD, Xiao-Pei Wang, MD, Yong-Qian Jia, MD, Ting Niu, MD PhD, Ting Liu, MDPhD, Ling Pan, MD, Zhuo-Gang Liu, MD, Tong Li, MD, Ying-Chun Li, MD, Kun Yao, MD, Xiaoyan Ke, MD PhD, Hongmei Jing, MD, Fang Bao, MD

Blood (2015) 126 (23): 264.

https://doi.org/10.1182/blood.V126.23.264.264

Published: 2015

Journal Articles

Long-Term HSC Donor Follow-up: Malignancy Incidences after Donation Are Identical Compared to a Matched Control Sample of Registered Donors, but Different to Expected General Population Rates

Thilo Mengling, MD, Camila J. Hernandez Frederick, PhD, Daniel Fandel, MS, Jürgen Sauter, PhD, Johannes Schetelig, MD M. Sc,, Alexander H. Schmidt, MD PhD, Gerhard Ehninger, MD

Blood (2015) 126 (23): 269.

https://doi.org/10.1182/blood.V126.23.269.269

Published: 2015

Journal Articles

Evan's Syndrome Associated with Pembrolizumab Therapy in Metastatic Non-Small Cell Lung Cancer

Anthony Lott, MD, Marcus Butler, MD, Natasha Leighl, MD, Christine M. Cserti-Gazdewich, MD

Blood (2015) 126 (23): 4543.

https://doi.org/10.1182/blood.V126.23.4543.4543

Published: 2015

Journal Articles

Mapping the Gene Expression Diversity Across Hematological and Lymphoid Malignancies

Thomas Liuksiala, Kirsi Granberg, Sergei Häyrynen, Juha Mehtonen, Petri Pölönen, Susanna Teppo, MSc, Jake Lin, Saara Laukkanen, Patrick May, Matti Nykter, Merja Heinäniemi, Olli Lohi

Blood (2015) 126 (23): 4805.

https://doi.org/10.1182/blood.V126.23.4805.4805

Published: 2015

Journal Articles

Engineering the Cancer Genome

Tyler Jacks, PhD

Blood (2015) 126 (23): SCI-19.

https://doi.org/10.1182/blood.V126.23.SCI-19.SCI-19

Published: 2015

Journal Articles

Identification of a Novel and Efficacious Oral Proteasome Inhibitor As a Potential Clinical Development Candidate

Kwang-Ai Won, PhD, Byung Gyu Kim, Cheol-Kyu Jung, Eok Park, Eunbok Baek, Jonghoon Park, Seung-Wan Kang, Tae Hun Kim, Youngjoo Jung

Blood (2014) 124 (21): 4808.

https://doi.org/10.1182/blood.V124.21.4808.4808

Published: 2014

Journal Articles

Insights Into the Mechanism of Zymogen Protein C Protection Against Cancer Progression

Julie M Crudele, BA, Geerte L. Van Sluis, MD, Paris Margaritis, DPhil, Joshua I Siner, Michael Sliozberg, Jenna Maurer, Armida Faella, Shangzhen Zhou, MD, Katherine A. High, MD, Charles T Esmon, PhD, C. Arnold Spek, PhD, Valder R Arruda, MD, PhD

Blood (2012) 120 (21): 3350.

https://doi.org/10.1182/blood.V120.21.3350.3350

Published: 2012

Journal Articles

Clathrin-Mediated Endocytosis of Neutrophil Elastase and Cathepsin G by Lung Tumor Epithelial Cells

Alyssa D. Gregory, PhD, Pamela D. Hale, David H. Perlmutter, MD, Steven D. Shapiro, MD, A. McGarry Houghton, MD

Blood (2012) 120 (21): 3269.

https://doi.org/10.1182/blood.V120.21.3269.3269

Published: 2012

Journal Articles

Efficacy and Safety of Three Bortezomib-Based Combinations in Elderly, Newly Diagnosed Multiple Myeloma Patients: Results From All Randomized Patients in the Community-Based, Phase 3b UPFRONT Study

Ruben Niesvizky, MD, Ian W. Flinn, MD, PhD, Robert Rifkin, MD, Nashat Gabrail, MD, Veena Charu, MD, Billy Clowney, MD, James Essell, MD, Yousuf Gaffar, MD, Thomas A. Warr, MD, FACP, Rachel Neuwirth, MS, Deyanira Corzo, MD, James Reeves, MD

Blood (2011) 118 (21): 478.

https://doi.org/10.1182/blood.V118.21.478.478

Published: 2011

Journal Articles

Nilotinib in Imatinib-Resistant or -Intolerant Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): 48-Month Follow-up Results of a Phase 2 Study,

Blood (2011) 118 (21): 3770.

https://doi.org/10.1182/blood.V118.21.3770.3770

Published: 2011

Journal Articles

In Vivo Bioluminescence Imaging to Study the Contribution of TNF-TNFR Interactions on Immune and Parenchymal Cells to Tumor Cell Progression in a Syngenic Mouse Model

Martin Chopra, Simone S Riedel, Viktoria von Krosigk, Carina A Bäuerlein, Christian Brede, Ana-Laura Jordan-Garrote, Stefanie Donat, Miriam Ritz, Axelle Degla, Hermann Einsele, Harald Wajant, Andreas Beilhack

Blood (2011) 118 (21): 1110.

https://doi.org/10.1182/blood.V118.21.1110.1110

Published: 2011

Journal Articles

Absence of Functional Epo Receptors In Normal and Cancerous Human Tissues and Cell Lines,

Steve Elliott, Susan Swift, Leigh Busse, John M Rossi, Ian McCaffery

Blood (2011) 118 (21): 3169.

https://doi.org/10.1182/blood.V118.21.3169.3169

Published: 2011

Journal Articles

TFPI-Beta Is An Effective Inhibitor of TF-FVIIa Mediated Coagulation and Tumor Cell Invasion

Susan A Maroney, DVM, PhD, Josephine P Ferrel, BS, Alan E. Mast, MD, PhD

Blood (2010) 116 (21): 347.

https://doi.org/10.1182/blood.V116.21.347.347

Published: 2010

Journal Articles

The Activated K-RAS Protein Accelerates Human Derived-MLL/AF4 Induced Leukemo-Lymphomogenicity In Transgenic Mice Model

Hayato Tamai, MD, Koichi Miyake, MD, PhD, Miyuki Takatori, Noriko Miyake, Hiroki Yamaguchi, MD, PhD, Kazuo Dan, MD, PhD, Takashi Shimada, MD, PHD, Koiti Inokuchi, PhD, MD

Blood (2010) 116 (21): 61.

https://doi.org/10.1182/blood.V116.21.61.61

Published: 2010

Journal Articles

Tumor Expression of Alternative Spliced Tissue Factor Is a Prognostic Marker in Non-Small Cell Lung Cancer.

Sandra Regina, MD, Jerome Rollin, PhD, Yves Gruel, MD

Blood (2009) 114 (22): 335.

https://doi.org/10.1182/blood.V114.22.335.335

Published: 2009

Journal Articles

Platelet Glycoprotein VI Contributes to Murine Experimental Metastasis

Shashank Jain, Susan Russell, Jerry Ware, PhD

Blood (2008) 112 (11): 2862.

https://doi.org/10.1182/blood.V112.11.2862.2862

Published: 2008

Journal Articles

Identification and Characterization of Hematopoietic Stem (HSC)/Progenitor Cells in Human Solid Tumors

Roland C Leung, MD, David C Dorn, MD, PhD, Robert J Downey, MD, Douglas A Levine, MD, Malcolm A.S. Moore, PhD

Blood (2008) 112 (11): 4785.

https://doi.org/10.1182/blood.V112.11.4785.4785

Published: 2008

Journal Articles

Alterations of P53 and PTEN Genes Are Associated with Increased TF Expression and Reduced Survival in Non Small Cell Lung Cancer

Sandra Regina, MD, Jean-Baptiste Valentin, Sébastien Lachot, Bruno Giraudeau, MD, Jerome Rollin, PhD, Yves Gruel, MD

Blood (2008) 112 (11): 1032.

https://doi.org/10.1182/blood.V112.11.1032.1032

Published: 2008

Journal Articles

Inactivating Icmt ameliorates K-RAS–induced myeloproliferative disease

Annika M. Wahlstrom, Briony A. Cutts, Meng Liu, Annika Lindskog, Christin Karlsson, Anna-Karin M. Sjogren, Karin M. E. Andersson, Stephen G. Young, Martin O. Bergo

Blood (2008) 112 (4): 1357–1365.

https://doi.org/10.1182/blood-2007-06-094060

Published: 2008

Includes: Supplemental data

Journal Articles

Primary Non-Hodgkin’s Lymphoma of the Lung.

Thomas Fong, MD, Izidore Lossos, M.D., Daniel Morgensztern, M.D.

Blood (2007) 110 (11): 4402.

https://doi.org/10.1182/blood.V110.11.4402.4402

Published: 2007

NARROW

4SCAR19 Chimeric Antigen Receptor-Modified T Cells As a Breakthrough Therapy for Highly Chemotherapy-Resistant Late-Stage B Cell Lymphoma Patients with Bulky Tumor Mass

Long-Term HSC Donor Follow-up: Malignancy Incidences after Donation Are Identical Compared to a Matched Control Sample of Registered Donors, but Different to Expected General Population Rates

Evan's Syndrome Associated with Pembrolizumab Therapy in Metastatic Non-Small Cell Lung Cancer

Mapping the Gene Expression Diversity Across Hematological and Lymphoid Malignancies

Engineering the Cancer Genome

Identification of a Novel and Efficacious Oral Proteasome Inhibitor As a Potential Clinical Development Candidate

Insights Into the Mechanism of Zymogen Protein C Protection Against Cancer Progression

Clathrin-Mediated Endocytosis of Neutrophil Elastase and Cathepsin G by Lung Tumor Epithelial Cells

Efficacy and Safety of Three Bortezomib-Based Combinations in Elderly, Newly Diagnosed Multiple Myeloma Patients: Results From All Randomized Patients in the Community-Based, Phase 3b UPFRONT Study

Nilotinib in Imatinib-Resistant or -Intolerant Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): 48-Month Follow-up Results of a Phase 2 Study,

In Vivo Bioluminescence Imaging to Study the Contribution of TNF-TNFR Interactions on Immune and Parenchymal Cells to Tumor Cell Progression in a Syngenic Mouse Model

Absence of Functional Epo Receptors In Normal and Cancerous Human Tissues and Cell Lines,

TFPI-Beta Is An Effective Inhibitor of TF-FVIIa Mediated Coagulation and Tumor Cell Invasion

The Activated K-RAS Protein Accelerates Human Derived-MLL/AF4 Induced Leukemo-Lymphomogenicity In Transgenic Mice Model

Tumor Expression of Alternative Spliced Tissue Factor Is a Prognostic Marker in Non-Small Cell Lung Cancer.

Platelet Glycoprotein VI Contributes to Murine Experimental Metastasis

Identification and Characterization of Hematopoietic Stem (HSC)/Progenitor Cells in Human Solid Tumors

Alterations of P53 and PTEN Genes Are Associated with Increased TF Expression and Reduced Survival in Non Small Cell Lung Cancer

Inactivating Icmt ameliorates K-RAS–induced myeloproliferative disease

Primary Non-Hodgkin’s Lymphoma of the Lung.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only